Our objectives were to identify the relative contributions of intracellular free Ca 2ϩ concentration ([Ca 2ϩ ]i) and myofilament Ca 2ϩ sensitivity in the pulmonary artery smooth muscle (PASM) contractile response to the ␣-adrenoreceptor agonist phenylephrine (PE) and to assess the role of PKC, tyrosine kinases (TK), and Rho kinase (ROK) appears to be one important mechanism of pharmacomechanical coupling (12). Activation of PKC (4, 5, 11, 22), tyrosine kinases (TK) (7, 18, 19, 42) , and/or Rho kinase (ROK) (18, 46) have been suggested to play important roles in the signal transduction events associated with vascular smooth muscle contraction. However, the relative roles of PKC, TK, and ROK in regulating [Ca 2ϩ ] i , myofilament Ca 2ϩ sensitivity, and tension in response to ␣-adrenoreceptor stimulation have not been fully elucidated.
]i) and myofilament Ca 2ϩ sensitivity in the pulmonary artery smooth muscle (PASM) contractile response to the ␣-adrenoreceptor agonist phenylephrine (PE) and to assess the role of PKC, tyrosine kinases (TK), and Rho kinase (ROK) in that response. Our hypothesis was that multiple signaling pathways are involved in the regulation of [Ca 2ϩ ]i, myofilament Ca 2ϩ sensitization, and vasomotor tone in response to ␣-adrenoreceptor stimulation of PASM. Simultaneous measurement of [Ca 2ϩ ]i and isometric tension was performed in isolated canine pulmonary arterial strips loaded with fura 2-AM. PE-induced tension development was due to sarcolemmal Ca 2ϩ influx, Ca 2ϩ release from inositol 1,4,5-trisphosphate-dependent sarcoplasmic reticulum Ca 2ϩ stores, and myofilament Ca 2ϩ sensitization. Inhibition of either PKC or TK partially attenuated the sarcolemmal Ca 2ϩ influx component and the myofilament Ca 2ϩ sensitizing effect of PE. Combined inhibition of PKC and TK did not have an additive attenuating effect on PE-induced Ca 2ϩ sensitization. ROK inhibition slightly decreased [Ca 2ϩ ]i but completely inhibited myofilament Ca 2ϩ sensitization. These results indicate that PKC and TK activation positively regulate sarcolemmal Ca 2ϩ influx in response to ␣-adrenoreceptor stimulation in PASM but have relatively minor effects on myofilament Ca 2ϩ sensitivity. ROK is the predominant pathway mediating PE-induced myofilament Ca 2ϩ sensitization.
intracellular calcium ion; myofilament calcium ion sensitivity; phenylephrine; vascular smooth muscle; pulmonary artery smooth muscle; protein kinase C CATECHOLAMINE-INDUCED ACTIVATION of ␣-adrenoreceptors on vascular smooth muscle cells results in an increase in vasomotor tone. Vasomotor tone is regulated by intracellular free Ca 2ϩ concentration ([Ca 2ϩ ] i ) and myofilament Ca 2ϩ sensitivity. The initial increase in tone is mediated by an increase in [Ca 2ϩ ] i , which triggers activation of myosin light chain kinase, myosin light chain phosphorylation, and an increase in tension. Maintenance of vascular smooth muscle contraction is more complex and likely involves several signaling pathways. Sensitization of the contractile apparatus to Ca 2ϩ appears to be one important mechanism of pharmacomechanical coupling (12) . Activation of PKC (4, 5, 11, 22) , tyrosine kinases (TK) (7, 18, 19, 42) , and/or Rho kinase (ROK) (18, 46) have been suggested to play important roles in the signal transduction events associated with vascular smooth muscle contraction. However, the relative roles of PKC, TK, and ROK in regulating [Ca 2ϩ ] i , myofilament Ca 2ϩ sensitivity, and tension in response to ␣-adrenoreceptor stimulation have not been fully elucidated.
Although the cellular mechanisms involved in ␣-adrenoreceptor-mediated vasoconstriction have been studied in a variety of systemic vascular smooth muscle types (14, 40, 45, 49) , comparatively less is known about the cellular mechanisms mediating ␣-adrenoreceptor activation in the pulmonary circulation. Moreover, differential responses to hypoxia in the systemic (vasodilation) vs. the pulmonary (vasoconstriction) circulation underscore the difficulty in extrapolating results obtained in systemic vascular smooth muscle to cellular mechanisms that regulate pulmonary vasomotor tone. In the pulmonary circulation, the extent to which PKC, TK, and ROK mediate ␣-adrenoreceptor pulmonary vasoconstriction is controversial (5, 18, 19, 22) . In endothelium-intact canine pulmonary artery smooth muscle (PASM) rings, norepinephrine-induced contractions were insensitive to PKC inhibitors but were abolished by TK inhibition and ROK inhibition (18) . In contrast, others demonstrated that the vasoconstrictor response to norepinephrine in the feline pulmonary vascular bed was attenuated by PKC inhibitors (22) and likely mediated by Ca 2ϩ -independent PKC-␦ isozyme/calmodulin-dependent kinase III (5) . Others suggested that the contractile response to norepinephrine in isolated rat pulmonary artery is largely mediated by TK activation (42) . In none of these studies were [Ca 2ϩ ] i and tension simultaneously measured in the same tissue so that the role of PKC, TK, or ROK ] i nor did it assess the role(s) of protein kinase activation in mediating increases in tension in response to ␣-adrenoreceptor activation (17) . The present study is unique in that our goal was to simultaneously measure [Ca 2ϩ ] i and tension in PASM strips and to identify the extent to which PKC, TK, and ROK modulate [Ca 2ϩ ] i and myofilament Ca 2ϩ sensitivity in response to ␣-adrenoreceptor stimulation with phenylephrine (PE).
MATERIALS AND METHODS
All surgical procedures and experimental protocols were approved by the Cleveland Clinic Foundation Institutional Animal Care and Use Committee (Cleveland, OH).
Preparation of pulmonary arterial strips. Heartworm-negative mongrel dogs (20-30 kg) were anesthetized with intravenous pentobarbital sodium (30 mg/kg) and fentanyl citrate (15 g/kg) and placed on positive-pressure ventilation. A catheter was inserted into the right femoral artery, and the dogs were exsanguinated by controlled hemorrhage. A left lateral thoracotomy was performed through the fifth intercostal space, and the heart was arrested with electrically induced ventricular fibrillation. The heart and lungs were removed from the thorax en bloc. Right and left intralobar pulmonary arteries [2-to 4-mm internal diameter (ID)] were dissected free and immersed in cold modified Krebs-Ringer bicarbonate (KRB) solution composed of (in mM) 118.3 NaCl, 4.7 KCl, 1.2 MgSO 4, 1.2 KH2PO4, 2.5 CaCl2, 25 NaHCO3, 0.016 Ca-EDTA, and 11.1 glucose. The pulmonary arteries were cleaned of fat and connective tissue and cut into strips (2 ϫ 8 mm) or rings (2-to 4-mm ID). The endothelium was denuded by gently rubbing the intimal surface with a cotton swab. The absence of an intact endothelium was later verified by assessing the vasorelaxant response to 10 Ϫ6 M acetylcholine.
Simultaneous measurement of [Ca 2ϩ ]i and tension. As described previously (37) , pulmonary arterial strips without endothelium were loaded with 5 M fura 2-AM at room temperature (22-24°C) . A noncytotoxic detergent, 0.05% cremophor EL, was added to solubilize the fura 2-AM in the solution and act as a vehicle for penetrating the tissue. After fura 2 loading, the muscle strips were washed with KRB buffer for 30-60 min to remove unhydrolyzed fura 2-AM and then placed between two stainless steel hooks in a temperature-controlled (37°C) cuvette (volume 3 ml), which was continuously perfused (12 ml/min) with KRB solution bubbled with 95% air-5% CO 2 (pH 7.4). One hook was anchored, and the other was connected to a strain gauge transducer (Grass model FTO3; Quincy, MA) to measure isometric force. The resting tension was adjusted to 4 g, which was determined in preliminary studies to be optimal for achieving a maximum contractile response to 20 mM KCl. Fluorescence measurements were performed with a dual-wavelength spectrofluorometer (Deltascan RFK6002; Photon Technology International, Lawrenceville, NJ) at excitation wavelengths of 340 and 380 nm and an emission wavelength of 510 nm. Fura 2 fluorescence signals (340 nm, 380 nm, and 340 nm-to-380 nm ratio) were continuously monitored at a sampling frequency of 2.5 Hz and collected with a software package from Photon Technology International. The 340-to-380 fluorescence ratio was used as an indicator of [Ca 2ϩ ]i. In control experiments, the baseline fluorescence intensities, as well as the signal ratios measured in the absence of dye, were not altered by any of the experimental interventions. After changes in tension and [Ca 2ϩ ]i in response to 60 mM KCl were measured, the strips were washed with fresh KRB for 30 min. All strips were pretreated with propranolol (5 M, 30 min) to inhibit the ␤-agonist effect of PE. A high dose of PE (10 M) was used throughout the study to achieve a significant increase in tension in protocols in which extracellular Ca 2ϩ was absent. The response to PE (10 M) was assessed in the presence (10 min) or absence of the PKC inhibitor (48) bisindolylmaleimide I (Bis I; 3 M), the TK inhibitor (26) ]i and tension after an intervention are expressed as the percent change from the previous response measured in that particular protocol.
Materials. Phenylephrine HCl, propranolol HCl, Tyr A47, Tyr A1, genistein, daidzein, Bis I, and Bis V were purchased from Sigma (St. Louis, MO). 2-APB and calphostin C were obtained from Calbiochem (La Jolla, CA). Y-27632 was obtained from Biomol (Plymouth Meeting, PA).
Statistical analysis and data presentation. Results are expressed as means Ϯ SE. The sample size, n, represents the number of dogs from which strips or rings were studied. Statistical comparisons used ANOVA and the BonferroniDunn post hoc test. Student's t-test for paired comparisons was used when appropriate. Differences were considered statistically significant at P Ͻ 0.05. Figure  1A illustrates simultaneous recordings of [Ca 2ϩ ] i and tension during exposure to 60 mM KCl and 10 M PE in a PASM strip. Addition of KCl resulted in rapid, early increases in [Ca 2ϩ ] i and tension, followed by late, sustained increases near peak levels until washout. PE caused early peak increases in [Ca 2ϩ ] i and tension followed by late, sustained increases at lower values. PE increased tension to a similar degree as KCl, whereas the increase in [Ca 2ϩ ] i was only about half of that observed with KCl. During washout of PE, tension remained elevated even when [Ca 2ϩ ] i had returned to baseline (Fig. 1A) . PE caused a leftward shift in the continuous [Ca 2ϩ ] i -tension relationship (Fig. 1B) . The reproducibility of the PE response was assessed by administering PE three successive times to PASM strips. As summarized in Fig. 2 , increases in [Ca and tension in response to the second and third applications of PE were similar although somewhat greater then the first response to PE. We next investigated the effects of the various interventions on the early (defined as the peak changes occurring within 2 min of PE application) and late (measured 15 min after administration of PE) changes in [Ca 2ϩ ] i and tension in response to PE in PASM strips.
RESULTS

Effect of KCl and PE on [Ca 2ϩ ] i and tension.
Effect ] i and tension by 32 Ϯ 6% and 55 Ϯ 5%, respectively. In the absence of extracellular Ca 2ϩ the late phase of the PE-induced increase in [Ca 2ϩ ] i was abolished, whereas the late phase of tension development was reduced by 65 Ϯ 2%.
Effect of IP 3 receptor inhibition in absence of extracellular Ca 2ϩ . Our next goal was to test the hypothesis that IP 3 -mediated release of Ca 2ϩ from intracellular stores is involved in the PE-induced contractile response. We pretreated the strips with the IP 3 receptor blocker 2-APB before PE stimulation in the absence of extracellular Ca 2ϩ (Fig. 4) . Inhibition of IP 3 receptors with 2-APB (100 M) abolished the early increase in [Ca 2ϩ ] i in response to PE and reduced the early increase in tension by 43 Ϯ 5% compared with that observed in the absence of extracellular Ca 2ϩ . 2-APB had no effect on the late PE-induced increase in tension.
Effect of PKC inhibition. To test the hypothesis that PKC activation plays a role in PE-induced increases in [Ca 2ϩ ] i and tension, PASM strips were pretreated with the PKC inhibitor Bis I before PE stimulation. In the presence of extracellular Ca 2ϩ , pretreatment with Bis I (3 M) had no effect on the early increase in [Ca 2ϩ ] i but reduced the late increase in [Ca 2ϩ ] i by 60 Ϯ 3% (Fig. 5) . Bis I reduced both the early (20 Ϯ 5%) and late (33 Ϯ 4%) increases in tension in response to PE. The inactive analog of Bis I (Bis V) had no effect on PE-induced increases in [Ca 2ϩ ] i or tension. To further confirm a role for PKC in PE-induced contraction, concentrationresponse curves for KCl and PE were obtained in PASM rings in the presence or absence of another specific PKC inhibitor, calphostin C. Because of the light-sensitive nature of calphostin C, [Ca 2ϩ ] i could not be measured in these studies. Pretreatment with calphostin C (1 M) for 60 min had no effect on resting tension or KCl-induced contraction (Fig. 6) . However, PE-induced contraction was inhibited by calphostin C, resulting in a 43 Ϯ 5% decrease in maximal tension.
Effect of PKC inhibition in absence of extracellular Ca 2ϩ . We next tested the hypothesis that PKC activation is involved in regulating the PE-induced increase in tension observed in the absence of extracellular . We pretreated strips with Bis I in the absence of extracellular Ca 2ϩ before stimulation with PE. In the absence of extracellular Ca 2ϩ , Bis I (3 M) had no effect on the early increase in [Ca 2ϩ ] i induced by PE but reduced the early increase in tension by 25 Ϯ 6% (Fig. 7) . Bis I had no significant effect on the late PE-induced increase in tension.
Effect of PKC inhibition in absence of extracellular Ca 2ϩ and IP 3 -mediated SR Ca 2ϩ release. We tested the hypothesis that the increase in tension observed in the absence of any increase in [Ca 2ϩ ] i is mediated by activation of PKC. PASM strips were pretreated with Bis I in the absence of extracellular Ca 2ϩ and in the presence of 2-APB before stimulation with PE. Under these conditions, PE-induced increases in tension were not associated with concomitant increases in [Ca 2ϩ ] i . As summarized in Fig. 8A , Bis I reduced both the PE-induced early (20 Ϯ 5%) and late (18 Ϯ 6%) increases in tension. 
Effect of TK inhibition.
To test the hypothesis that activation of TK plays a role in PE-induced increases in [Ca 2ϩ ] i and tension, we pretreated PASM strips with the TK inhibitor Tyr A47 before PE stimulation. Pretreatment with Tyr A47 (10 M) had no effect on the early increase in [Ca 2ϩ ] i but, surprisingly, enhanced the late increase in [Ca 2ϩ ] i by 79 Ϯ 20% (Fig. 9) . Tyr A47 had no effect on the early increase in tension but enhanced the late increase in tension by 20 Ϯ 8%. The inactive analog of Tyr A47 (Tyr A1; 10 M) did not alter PE-induced increases in [Ca 2ϩ ] i or tension. In contrast to Tyr A47, pretreatment with genistein (100 M) reduced the early increase in [Ca 2ϩ ] i and tension by 55 Ϯ 6% and 38 Ϯ 12%, respectively. Genistein also reduced the late increases in [Ca 2ϩ ] i and tension by 60 Ϯ 8% and 20 Ϯ 8%, respectively. The inactive analog of genistein (daidzein; 100 M) had no effect on PEinduced increases in [Ca 2ϩ ] i or tension.
Effect of TK inhibition in absence of extracellular Ca
2ϩ . We tested the hypothesis that activation of TK is involved in regulating the PE-induced increase in tension observed in the absence of extracellular Ca 2ϩ . PASM strips were pretreated with Tyr A47 in the absence of extracellular Ca 2ϩ before stimulation with PE. Similar to Bis I, Tyr A47 (10 M) had no effect on the early increase in [Ca 2ϩ ] i in response to PE but reduced the early increase in tension by 22 Ϯ 6% (Fig.  10) . Tyr A47 had no effect on late changes in tension. absence of any increase in [Ca 2ϩ ] i is mediated by activation of TK, we pretreated strips with Tyr A47 in the absence of extracellular Ca 2ϩ and in the presence of 2-APB before stimulation with PE. As noted above, under these conditions PE-induced increases in tension were not associated with concomitant increases in [Ca 2ϩ ] i . As summarized in Fig. 8B , Tyr A47 reduced the early (34 Ϯ 3%) and late (30 Ϯ 5%) increases in tension in response to PE.
Effect of combined TK and PKC inhibition in absence of extracellular Ca
2ϩ and IP 3 -mediated SR Ca 2ϩ release. We also tested the hypothesis that the effects of PKC and TK on myofilament Ca 2ϩ sensitization were additive (i.e., the signaling pathways are in parallel). PASM strips were pretreated with both Bis I and Tyr A47 in the absence of extracellular Ca 2ϩ and in the presence of 2-APB before stimulation with PE. As summarized in Fig. 8C , the effect of combined PKC and TK inhibition on PE-induced contraction was no greater than that observed with Bis I or Tyr A47 alone.
Effect of ROK inhibition. To test the hypothesis that ROK plays a role in PE-induced increases in [Ca 2ϩ ] i and tension, PASM strips were pretreated with the ROK inhibitor Y-27632 before PE stimulation. In the presence of extracellular Ca 2ϩ , pretreatment with Y-27632 (10 M) reduced the early (21 Ϯ 7%) but not the late increase in [Ca 2ϩ ] i in response to PE (Fig. 11) . However, pretreatment with Y-27632 reduced both the early and late PE-induced increases in tension by 52 Ϯ 7% and 54 Ϯ 8%, respectively. in the presence of 2-APB before stimulation with PE. Under these conditions, inhibition of ROK with Y-27632 (10 M) abolished PE-induced contraction (Fig. 8D) .
Effect of ROK inhibition in absence of extracellular
DISCUSSION
To our knowledge, this is the first study to simultaneously measure PE-induced changes in [Ca 2ϩ ] i and tension in PASM in the presence and absence of extracellular Ca 2ϩ before and after inhibition of PKC, TK, ROK, and IP 3 receptors. Our results indicate the following. Transsarcolemmal Ca 2ϩ influx and myofilament Ca 2ϩ sensitization contribute to both the early and late increases in tension. IP 3 receptor-mediated release of Ca 2ϩ from the sarcoplasmic reticulum contributes to the increase in early tension but not the late phase of tension. PKC and TK activation positively regulate both PE-induced Ca 2ϩ influx and myofilament Ca 2ϩ sensitization. The effects of PKC and TK on myofilament Ca 2ϩ sensitivity were comparatively minor and not additive. Finally, ROK is the predominant pathway mediating PE-induced myofilament Ca 2ϩ sensitization. However, it should be noted that the relative roles of these pathways may vary depending on the stimulus intensity and/or degree of resting tension. In addition, cross talk (30, 39) likely occurs between these pathways and may account for some of the differences observed in other studies (18, 42) .
[ . Both the early and late increases in tension were reduced when extracellular Ca 2ϩ was removed, indicating that transsarcolemmal Ca 2ϩ influx plays a major role in PE-induced contraction in PASM. For reasons that remain unclear, our results appear to be in direct contrast to a recent study that reported that removal of extracellular Ca 2ϩ or administration of voltage-gated Ca 2ϩ channel blockers had no effect on tension development in response to ␣-adrenoreceptor stimulation in endothelium-intact PASM (18) . However, in a separate study, PE-induced contractions were found to be reduced by Ͼ75% in a nominally Ca 2ϩ -free buffer and involved a nisoldipine-insensitive, SK&F-96365-sensitive Ca 2ϩ influx pathway (17) . In that same study, depletion of IP 3 -sensitive Ca 2ϩ stores, but not caffeine-sensitive Ca 2ϩ stores, nearly abolished the PE response. This study by Jabr and coworkers (17) suggests that a nisoldipine-insensitive Ca 2ϩ entry pathway is normally involved in filling IP 3 -sensitive Ca 2ϩ stores -independent mechanism involved, rather than an increase in myofilament Ca 2ϩ sensitivity. However, these two possibilities are not mutually exclusive and may exist in parallel or be linked to each other (i.e., Ca 2ϩ -independent pathway triggering an increase in myofilament Ca 2ϩ sensitivity). This could be achieved through activation of PKC, TK, ROK, or a yet unidentified pathway. Thus we next investigated the roles of PKC, TK, and ROK in mediating this effect, as well as PE-induced changes in Ca 2ϩ influx. PKC. PKC activation is concomitant with IP 3 production in response to agonist stimulation of phospholipase C (50). Alternatively, agonist activation of phospholipase D (1, 34) or phospholipase A 2 (10, 38) can result in PKC activation in the absence of IP 3 produc- tion. PKC has been reported to play a role in ␣-adrenoreceptor-mediated pulmonary vasoconstriction in isolated cat and rat lung (5, 22) . In contrast, a recent report indicated that PKC is not involved in ␣-adrenoreceptor-mediated Ca 2ϩ influx or contraction in endothelium-intact canine pulmonary artery (18) . To resolve this controversy, we assessed the extent to which PKC mediates increases in [Ca 2ϩ ] i and tension simultaneously in response to PE. PKC inhibition with Bis I attenuated the PE-induced late increases in [Ca 2ϩ ] i and tension, which suggests that a component of the late increase in tension is mediated by PKC-dependent sarcolemmal Ca 2ϩ influx. Bis I had no effect on KClinduced increases in [Ca 2ϩ ] i or tension, indicating that its effect was not due to some nonspecific action on myosin light chain kinase. Moreover, calphostin C, a structurally different PKC inhibitor, also attenuated PE-induced, but not KCl-induced, contraction. These data are consistent with other studies that demonstrated that PKC activation by phorbol esters enhances L-type channel-mediated Ca 2ϩ influx in some smooth muscle cells (28) as well as ␣-adrenoreceptorstimulated Ca 2ϩ influx through voltage-gated Ca 2ϩ channels in rat portal vein and tail artery (25) . Our results clearly indicate that PKC activation is involved in ␣-adrenoreceptor-mediated contraction of canine PASM. After removal of extracellular Ca 2ϩ and pretreatment with 2-APB, the PE-induced increase in tension, without a concomitant increase in [Ca 2ϩ ] i , likely reflects an increase in myofilament Ca 2ϩ sensitivity. Under these conditions, Bis I attenuated the PE-induced increase in tension, albeit only by 20% (Fig. 7A) . These results indicate that PKC activation plays a relatively minor role in the Ca 2ϩ -sensitizing effect of PE. Potential mechanisms could include PKC-dependent activation of Na ϩ /H ϩ exchange and intracellular alkalinization causing myofilament Ca 2ϩ sensitization (23) or PKC-dependent inhibition of myosin light chain phosphatase via phosphorylation of CPI-17, an inhibitor of the catalytic subunit on the phosphatase (27, 46) . Alternatively, PKC-dependent activation of the thin filament accessory proteins caldesmon or calponin may be involved (3, 13, 33) . However, the fact that PE increased tension in the absence of an increase in [Ca 2ϩ ] i and after PKC inhibition indicates that additional signaling pathways are involved.
TK. Because TK activation has also been implicated in the contractile response to ␣-adrenoreceptor activation in the pulmonary circulation (8, 18, 42) , we assessed the extent to which inhibition of TK regulates [Ca 2ϩ ] i and tension in response to PE. Much to our surprise, pretreatment with Tyr A47 appeared to enhance the late increase in [Ca 2ϩ ] i and tension in response to PE when extracellular Ca 2ϩ was present (Fig. 9) . Tyr A47 was shown to exert no effect on arginine vasopressin-induced increases in Ca 2ϩ in A7r5 aortic smooth muscle cells (21) . In contrast, other studies demonstrated that inhibition of TK with various Tyr derivatives results in decreased Ca 2ϩ entry in vascular smooth muscle cells (21, 43, 51, 52) . It should be noted that repetitive exposure to PE alone was associated with slightly potentiated late increases in [Ca 2ϩ ] i and tension (Fig. 2) . This effect may explain, at least in part, the late PE-induced increases in [Ca 2ϩ ] i and tension after Tyr A47. Alternatively, the effects of Tyr A47 could potentially be explained by the finding that some TK inhibitors, including Tyr A47, actually enhance tyrosine phosphorylation (6, 21) . To further investigate this unexpected finding, we assessed the effects of a more widely used and structurally different TK inhibitor, genistein. In contrast to Tyr A47, genistein attenuated both the early and late increases in [Ca 2ϩ ] i and tension in response to PE. This effect was observed in the presence and absence of extracellular Ca 2ϩ . These results suggest that a component of PE-induced contraction is due to Ca 2ϩ release and transsarcolemmal Ca 2ϩ influx. Our results with genistein are consistent with our previous finding (8) that TK inhibition caused a rightward shift in the PE-induced concentration-response relationship in pulmonary arterial rings and provide additional support for the idea that TK plays a role in regulating ␣-adrenoreceptor-mediated increases in [Ca 2ϩ ] i and tension in PASM strips.
We also observed that TK inhibition in the absence of sarcolemmal Ca 2ϩ influx and after IP 3 receptor block attenuated PE-induced contraction (Fig. 8B) . Under these conditions, the PE-induced increase in tension likely involves a TK-dependent increase in myofilament Ca 2ϩ sensitivity. However, the importance of TK activation in the myofilament Ca 2ϩ -sensitizing effect of PE appears to be relatively minor (similar to PKC), again suggesting that another signaling pathway may play a greater role in PEinduced Ca 2ϩ sensitization. Combined TK and PKC inhibition. Controversy surrounding the relative roles of PKC and TK in mediating the overall Ca 2ϩ -sensitizing effect of PE in the pulmonary vasculature (5, 18) led us to assess the extent to which combined inhibition of PKC and TK attenuated PE-induced Ca 2ϩ sensitization. The effect of combined inhibition of PKC and TK on the PE-induced increase in tension in the absence of extracellular Ca 2ϩ and in the presence of 2-APB was not additive, suggesting that PKC and TK were acting via a final common pathway. Inhibition of myosin light chain phosphatase is a possible candidate (46) .
ROK. Recent evidence in a variety of smooth muscle preparations (16, 36) , including PASM (18, 46) , suggests that activation of ROK by the active GTPase RhoA may be a key mediator of Ca 2ϩ sensitization in response to G protein-coupled receptor activation. ROK phosphorylates the regulatory subunit of myosin light chain phosphatase and inhibits its catalytic activity, thus resulting in increased myosin light chain phosphorylation, Ca 2ϩ sensitization, and increased tension (46 (16) . The reduction in both PE-induced early and late tension is likely explained by a modest reduction in Ca 2ϩ availability but primarily by a decrease in the sensitizing component of the late contraction. ROK inhibition abolished the contractile response to PE in the absence of extracellular Ca 2ϩ and after IP 3 receptor block, indicating that ROK activation is the predominant pathway mediating PE-induced Ca 2ϩ sensitization (Fig. 8D) . Activation of ROK by PE may be due to the GTPase RhoA (46) or the release of arachidonic acid in response to PE (37, 46) .
Relative roles of signaling pathways. As noted above, the inhibitory effects of PKC and TK inhibition (alone and in combination) on PE-induced contraction in the absence of changes in [Ca 2ϩ ] i were relatively modest and not additive, whereas ROK inhibition abolished PE-induced contraction under these conditions. ROK inhibition also blocked about half of the PE-induced contraction when Ca 2ϩ was available. These results suggest that PKC and TK play a relatively minor role in mediating PE-induced late tension and that they act via a final common pathway. TK-dependent activation of ROK (18, 41) or PKC-dependent activation of ROK (32, 44) may explain these findings. PKC activation may serve dual roles in the PE response by positively regulating the L-type Ca 2ϩ current (47, 53) and enhancing myofilament Ca 2ϩ sensitivity, possibly via interactions with CPI-17 (27) . TK activation also appears to positively regulate sarcolemmal Ca 2ϩ influx in PASM, which is consistent with studies in other vascular beds (24, 29) . TK positively regulates myofilament Ca 2ϩ sensitivity, perhaps via direct phosphorylation of tyrosine residues on myosin light chain phosphatase (30, 39, 41) . RhoA activation of ROK could exert a direct effect on myosin light chain phosphatase activity to enhance myofilament Ca 2ϩ sensitivity (46) . Phosphorylation of calponin by ROK (20) , PKC (33), or TK (31) is another potentially important pathway. Further studies will be required to fully elucidate these interactions.
In summary, our results suggest that PE activates multiple signaling pathways that mediate ␣-adrenoreceptor contraction in PASM via modulation of both [Ca 2ϩ ] i and myofilament Ca 2ϩ sensitization. PKC and TK activation positively regulate sarcolemmal Ca 2ϩ influx and also play a relatively minor role in the regulation of myofilament Ca 2ϩ sensitization via a fi- nal common pathway. ROK activation is the primary mechanism for regulating myofilament Ca 2ϩ sensitization in response to PE in PASM.
